Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine programmes and policies.

D M Salisbury1, P C L Beverley, E Miller

  • 1Department of Health, London, UK.

British Medical Bulletin
|August 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Introduction of Group C Conjugate Meningococcal Vaccine into the UK.

Methods in molecular medicine·2011
Same author

Public perception of immunisation.

Lancet (London, England)·2004
Same author

Sero-epidemiology of mumps in western Europe.

Epidemiology and infection·2003
Same author

Severe and unrecognised: pertussis in UK infants.

Archives of disease in childhood·2003
Same author

Measurement and interpretation of pneumococcal IgG levels for clinical management.

Clinical and experimental immunology·2003
Same author

Nutrient removal from wastewaters using high performance materials.

Water science and technology : a journal of the International Association on Water Pollution Research·2003
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Effective national vaccine strategies require robust disease surveillance, cost-effectiveness analysis, and mathematical modeling for optimal delivery. Public confidence in vaccine safety is crucial, necessitating vigilant monitoring and investigation of any adverse events.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Economics

Background:

  • National vaccine strategies are essential for disease prevention but face challenges.
  • Budgetary constraints and the emergence of new vaccines necessitate careful planning.
  • Declining disease prevalence and vaccine safety concerns pose threats to vaccination programs.

Purpose of the Study:

  • To outline the essential components for effective national vaccine strategy management.
  • To address the challenges of vaccine selection, delivery, and public confidence.
  • To emphasize the integration of surveillance, economic analysis, and modeling for optimal immunization programs.

Main Methods:

  • Disease surveillance for accurate prevalence data.
  • Economic analysis focusing on cost-effectiveness.

Related Experiment Videos

  • Mathematical modeling for optimizing vaccine delivery strategies.
  • Monitoring and investigation of vaccine safety and side-effects.

    • Main Results:

    • Strategic planning integrating surveillance, economic analysis, and modeling is key to rational vaccine choice and delivery.
    • Effective immunization programs require integration with existing health facilities with minimal disruption.
    • Public reassurance on vaccine safety relies on robust detection and investigation of adverse events.

    Conclusions:

    • A successful national vaccine strategy depends on integrating disease surveillance, economic evaluation, and mathematical modeling.
    • Addressing public concerns about vaccine safety through rigorous monitoring is paramount.
    • Optimal vaccine delivery requires careful planning that aligns with public health goals and resource availability.